Quick Takeaways
- NOVARTIS PHARMA AG filed SCHEDULE 13G/A for PRECISION BIOSCIENCES INC Common stock, par value $0.000005 per share (DTIL).
- Disclosed ownership: 3.7%.
- Date of event: 30 Jun 2025.
NOVARTIS PHARMA AG - 30 Jun 2025 SCHEDULE 13G/A Report for PRECISION BIOSCIENCES INC Common stock, par value $0.000005 per share (DTIL)
- Filing Manager
- NOVARTIS PHARMA AG
- Reporting Manager
- Novartis Pharma AG
- Symbol
- DTIL
- Shares outstanding
- 11,177,865 shares
- Disclosed Ownership
- 413,581 shares
- Ownership
- 3.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Aug 2025, 16:01:15 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 12 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"NOVARTIS PHARMA AG disclosed 3.7% ownership in PRECISION BIOSCIENCES INC Common stock, par value $0.000005 per share (DTIL) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 12 Feb 2025.
- Current filing was accepted on 06 Aug 2025, 16:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Novartis Pharma AG | 3.7% | 413,581 | 0 | 413,581 | /s/ Christian Rehm | Christian Rehm / Authorised Signatory | |
| Novartis AG | 3.7% | 413,581 | 0 | 413,581 | /s/ Christian Rehm | Christian Rehm / Authorised Signatory |